45.00 -1.77 (-3.79%)
BIIB
Stock Details
Last Trade:45.00 Change:-1.77 (-3.79%) Prev Close:46.77 Open: 46.71 Days Range:44.80 – 47.22 52 Week Range: 37.21 - 73.59 Volume:5113072 P/E: 15.31EPS:2.94
View AllRecent Alerts 07/02/09
Recent Alert on 07/02/09 at 8:49am
Biogen Idec (BIIB) volatility low into JNJ $1B investment in Elan
Biogen Idec (BIIB) volatility low into JNJ $1B investment in Elan
Biogen Idec (Nasdaq: BIIB) : Biogen Idec closed at $46.77. Johnson and Johnson-JNJ will acquire 18.4% stake in Elan-ELN for $1B. Biogion and ELN are partners in Tysabri, a multiple sclerosis drug. Biogen July option implied volatility is at 41,... Read More
Recent Alert on 07/02/09 at 8:47am
Leerink Swann Upgrades Acorda Therapeutics (ACOR) Two-Notches to Outperform
Leerink Swann Upgrades Acorda Therapeutics (ACOR) Two-Notches to Outperform
Recent Alert on 07/01/09 at 7:22am
Acorda (ACOR) Enters License Agreement With Biogen Idec (BIIB) For Fampridine-SR Outside the U.S.
Acorda (ACOR) Enters License Agreement With Biogen Idec (BIIB) For Fampridine-SR Outside the U.S.
Recent Alert on 06/30/09 at 4:45pm
UCB and Biogen Idec (BIIB) Announce The Discontinuation of Phase II Trials of CDP323 for MS
UCB and Biogen Idec (BIIB) Announce The Discontinuation of Phase II Trials of CDP323 for MS
View AllRecent Press Releases
Press Release on 07/02/09 at 4:01pm
Biogen Idec to Report Second Quarter 2009 Financial Results on July 16, 2009
Biogen Idec to Report Second Quarter 2009 Financial Results on July 16, 2009
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 06/29/09 at 11:40am
Analyst upgrades, downgrades and initiations: AA, BIIB, JCP, KBH, WW ...
Analyst upgrades, downgrades and initiations: AA, BIIB, JCP, KBH, WW ...